161 related articles for article (PubMed ID: 17574450)
1. Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M.
Durigova M; Roughley PJ; Mort JS
Osteoarthritis Cartilage; 2008 Jan; 16(1):98-104. PubMed ID: 17574450
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
Durigova M; Troeberg L; Nagase H; Roughley PJ; Mort JS
Eur Cell Mater; 2011 Jan; 21():31-45. PubMed ID: 21225593
[TBL] [Abstract][Full Text] [Related]
3. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
4. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration.
Little CB; Flannery CR; Hughes CE; Goodship A; Caterson B
Osteoarthritis Cartilage; 2005 Feb; 13(2):162-70. PubMed ID: 15694578
[TBL] [Abstract][Full Text] [Related]
5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
Durigova M; Soucy P; Fushimi K; Nagase H; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2008 Oct; 16(10):1245-52. PubMed ID: 18372197
[TBL] [Abstract][Full Text] [Related]
8. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
[TBL] [Abstract][Full Text] [Related]
9. Intra-articular injection of tumor necrosis factor-alpha in the rat: an acute and reversible in vivo model of cartilage proteoglycan degradation.
Malfait AM; Tortorella M; Thompson J; Hills R; Meyer DM; Jaffee BD; Chinn K; Ghoreishi-Haack N; Markosyan S; Arner EC
Osteoarthritis Cartilage; 2009 May; 17(5):627-35. PubMed ID: 19026578
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
[TBL] [Abstract][Full Text] [Related]
11. Link protein can retard the degradation of hyaluronan in proteoglycan aggregates.
Rodriguez E; Roughley P
Osteoarthritis Cartilage; 2006 Aug; 14(8):823-9. PubMed ID: 16584896
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of hyaluronan export prevent proteoglycan loss from osteoarthritic cartilage.
Prehm P
J Rheumatol; 2005 Apr; 32(4):690-6. PubMed ID: 15801027
[TBL] [Abstract][Full Text] [Related]
13. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
14. Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation.
Karsdal MA; Sumer EU; Wulf H; Madsen SH; Christiansen C; Fosang AJ; Sondergaard BC
Arthritis Rheum; 2007 May; 56(5):1549-58. PubMed ID: 17469134
[TBL] [Abstract][Full Text] [Related]
15. Cartilage degradation independent of MMP/aggrecanases.
Sugimoto K; Iizawa T; Harada H; Yamada K; Katsumata M; Takahashi M
Osteoarthritis Cartilage; 2004 Dec; 12(12):1006-14. PubMed ID: 15564068
[TBL] [Abstract][Full Text] [Related]
16. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
[TBL] [Abstract][Full Text] [Related]
17. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.
Patwari P; Kurz B; Sandy JD; Grodzinsky AJ
Arch Biochem Biophys; 2000 Feb; 374(1):79-85. PubMed ID: 10640399
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]